An observational study of molecular profIling of advanced and aggRessive ENdometrial cancer and 1-st line treatment approaches in Russian Federation

Trial Identifier: D0817R00117
Sponsor: AstraZeneca
Start Date: June 2025
Primary Completion Date: June 2027
Study Completion Date: June 2027
Condition: Endometriosis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Russia Arkhangelsk, Russia
Russia Barnaul, Russia
Russia Chelyabinsk, Russia
Russia Ekaterinburg, Russia
Russia Irkutsk, Russia
Russia Izhevsk, Russia
Russia Krasnodar, Russia
Russia Krasnoyarsk, Russia
Russia Moscow, Russia
Russia Murmansk, Russia
Russia Obninsk, Russia
Russia Saint Petersburg, Russia
Russia Severodvinsk, Russia
Russia Sochi, Russia
Russia Tomsk, Russia
Russia Tver, Russia
Russia Ufa, Russia
Russia Vladivostok, Russia
Russia Yaroslavl, Russia